eslicarbazepine acetate has been researched along with milnacipran in 1 studies
Studies (eslicarbazepine acetate) | Trials (eslicarbazepine acetate) | Recent Studies (post-2010) (eslicarbazepine acetate) | Studies (milnacipran) | Trials (milnacipran) | Recent Studies (post-2010) (milnacipran) |
---|---|---|---|---|---|
229 | 68 | 175 | 473 | 112 | 187 |
Protein | Taxonomy | eslicarbazepine acetate (IC50) | milnacipran (IC50) |
---|---|---|---|
Cytochrome P450 2D6 | Homo sapiens (human) | 0.064 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 5.5 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.782 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bridgeman, MB; Dalal, KS | 1 |
1 other study(ies) available for eslicarbazepine acetate and milnacipran
Article | Year |
---|---|
Neurologic and psychiatric medications.
Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Cyclopropanes; Dibenzazepines; Drug Therapy; Humans; Mental Disorders; Milnacipran; Nervous System Diseases; Nimodipine | 2015 |